The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit
later.
We apologize for any inconvenience caused
ban nao wei chu xue de ji xing nao geng si chu xue xing zhuan hua de wei xian yin su
Author(s): XU Jing, YOU Fenghua
Pages: 226-
228
Year: 2017
Issue:
3
Journal: Journal of Clinical Neurology
Abstract: 脑梗死出血性转化(HT)是急性脑梗死的一种常见并发症,发生率约为8.5%~30%,其中有症状的约1.5%~5%[1].大多数HT无症状,10%急性脑梗死患者溶栓治疗后早期因为HT神经功能恶化[2],预测HT对于评估预后、溶栓治疗选择有重要意义.脑微出血(CMBs)是脑内微小血管病变引起的,反应了小血管的出血倾向,临床上无典型症状和体征.CMBs的存在可能是缺血性脑梗死发生HT的一个独立的危险因素和预测指标,CMBs是否是应用溶栓药或抗栓药的禁忌证仍不明确.对伴CMBs的急性脑梗死患者,溶栓、抗血小板聚集、抗凝及高血压、降脂治疗等因素是否会增加HT的风险仍不明确.本文就目前部分研究成果综述如下.
Citations
No citation found
Related Articles
No related articles found